Enliven Therapeutics, Inc.: Form 8-K/A, filed May 29, 2024

Filed with the SEC on May 29, 2024 and accepted by EDGAR at May 29, 2024, 16:06 ET.

Share this page

Link

X
Threads
Bluesky
LinkedIn
Facebook
Reddit
WhatsApp
Telegram
Pinterest
Hacker News
Email

Story card, 1080 × 1920

Items reported

Item 5.02 Departure or appointment of officers or directors

Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.

Source: SEC EDGAR, the filing index for accession 0001193125-24-149141. Last ingested by Listed: Nov 5, 2026, 17:49 ET. Listed shows no prices and gives no investment advice.